Annexin 2A sustains glioblastoma cell dissemination and proliferation

Francesca Maule, Silvia Bresolin, Elena Rampazzo, Daniele Boso, Alessandro Della Puppa, Giovanni Esposito, Elena Porcù, Stefania Mitola, Giuseppe Lombardi, Benedetta Accordi, Manuela Tumino, Giuseppe Basso, Luca Persano

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Glioblastoma (GBM) is the most devastating tumor of the brain, characterized by an almost inevitable tendency to recur after intensive treatments and a fatal prognosis. Indeed, despite recent technical improvements in GBM surgery, the complete eradication of cancer cell disseminated outside the tumor mass still remains a crucial issue for glioma patients management. In this context, Annexin 2A (ANXA2) is a phospholipid-binding protein expressed in a variety of cell types, whose expression has been recently associated with cell dissemination and metastasis in many cancer types, thus making ANXA2 an attractive putative regulator of cell invasion also in GBM. Here we show that ANXA2 is over-expressed in GBM and positively correlates with tumor aggressiveness and patient survival. In particular, we associate the expression of ANXA2 to a mesenchymal and metastatic phenotype of GBM tumors. Moreover, we functionally characterized the effects exerted by ANXA2 inhibition in primary GBM cultures, demonstrating its ability to sustain cell migration, matrix invasion, cytoskeletal remodeling and proliferation. Finally, we were able to generate an ANXA2-dependent gene signature with a significant prognostic potential in different cohorts of solid tumor patients, including GBM. In conclusion, we demonstrate that ANXA2 acts at multiple levels in determining the disseminating and aggressive behaviour of GBM cells, thus proving its potential as a possible target and strong prognostic factor in the future management of GBM patients.

Original languageEnglish
Pages (from-to)54632-54649
Number of pages18
JournalOncotarget
Volume7
Issue number34
DOIs
Publication statusPublished - 2016

Fingerprint

Annexins
Glioblastoma
Cell Proliferation
Neoplasms
Brain Neoplasms
Glioma
Cell Movement
Phospholipids
Carrier Proteins
Neoplasm Metastasis
Phenotype

Keywords

  • Annexin 2A
  • Cell cycle
  • Cytoskeletal remodeling
  • Glioblastoma
  • Invasion

ASJC Scopus subject areas

  • Oncology

Cite this

Maule, F., Bresolin, S., Rampazzo, E., Boso, D., Della Puppa, A., Esposito, G., ... Persano, L. (2016). Annexin 2A sustains glioblastoma cell dissemination and proliferation. Oncotarget, 7(34), 54632-54649. https://doi.org/10.18632/oncotarget.10565

Annexin 2A sustains glioblastoma cell dissemination and proliferation. / Maule, Francesca; Bresolin, Silvia; Rampazzo, Elena; Boso, Daniele; Della Puppa, Alessandro; Esposito, Giovanni; Porcù, Elena; Mitola, Stefania; Lombardi, Giuseppe; Accordi, Benedetta; Tumino, Manuela; Basso, Giuseppe; Persano, Luca.

In: Oncotarget, Vol. 7, No. 34, 2016, p. 54632-54649.

Research output: Contribution to journalArticle

Maule, F, Bresolin, S, Rampazzo, E, Boso, D, Della Puppa, A, Esposito, G, Porcù, E, Mitola, S, Lombardi, G, Accordi, B, Tumino, M, Basso, G & Persano, L 2016, 'Annexin 2A sustains glioblastoma cell dissemination and proliferation', Oncotarget, vol. 7, no. 34, pp. 54632-54649. https://doi.org/10.18632/oncotarget.10565
Maule F, Bresolin S, Rampazzo E, Boso D, Della Puppa A, Esposito G et al. Annexin 2A sustains glioblastoma cell dissemination and proliferation. Oncotarget. 2016;7(34):54632-54649. https://doi.org/10.18632/oncotarget.10565
Maule, Francesca ; Bresolin, Silvia ; Rampazzo, Elena ; Boso, Daniele ; Della Puppa, Alessandro ; Esposito, Giovanni ; Porcù, Elena ; Mitola, Stefania ; Lombardi, Giuseppe ; Accordi, Benedetta ; Tumino, Manuela ; Basso, Giuseppe ; Persano, Luca. / Annexin 2A sustains glioblastoma cell dissemination and proliferation. In: Oncotarget. 2016 ; Vol. 7, No. 34. pp. 54632-54649.
@article{d25ca2b4079a4fd396b61f42f4e9c57b,
title = "Annexin 2A sustains glioblastoma cell dissemination and proliferation",
abstract = "Glioblastoma (GBM) is the most devastating tumor of the brain, characterized by an almost inevitable tendency to recur after intensive treatments and a fatal prognosis. Indeed, despite recent technical improvements in GBM surgery, the complete eradication of cancer cell disseminated outside the tumor mass still remains a crucial issue for glioma patients management. In this context, Annexin 2A (ANXA2) is a phospholipid-binding protein expressed in a variety of cell types, whose expression has been recently associated with cell dissemination and metastasis in many cancer types, thus making ANXA2 an attractive putative regulator of cell invasion also in GBM. Here we show that ANXA2 is over-expressed in GBM and positively correlates with tumor aggressiveness and patient survival. In particular, we associate the expression of ANXA2 to a mesenchymal and metastatic phenotype of GBM tumors. Moreover, we functionally characterized the effects exerted by ANXA2 inhibition in primary GBM cultures, demonstrating its ability to sustain cell migration, matrix invasion, cytoskeletal remodeling and proliferation. Finally, we were able to generate an ANXA2-dependent gene signature with a significant prognostic potential in different cohorts of solid tumor patients, including GBM. In conclusion, we demonstrate that ANXA2 acts at multiple levels in determining the disseminating and aggressive behaviour of GBM cells, thus proving its potential as a possible target and strong prognostic factor in the future management of GBM patients.",
keywords = "Annexin 2A, Cell cycle, Cytoskeletal remodeling, Glioblastoma, Invasion",
author = "Francesca Maule and Silvia Bresolin and Elena Rampazzo and Daniele Boso and {Della Puppa}, Alessandro and Giovanni Esposito and Elena Porc{\`u} and Stefania Mitola and Giuseppe Lombardi and Benedetta Accordi and Manuela Tumino and Giuseppe Basso and Luca Persano",
year = "2016",
doi = "10.18632/oncotarget.10565",
language = "English",
volume = "7",
pages = "54632--54649",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "34",

}

TY - JOUR

T1 - Annexin 2A sustains glioblastoma cell dissemination and proliferation

AU - Maule, Francesca

AU - Bresolin, Silvia

AU - Rampazzo, Elena

AU - Boso, Daniele

AU - Della Puppa, Alessandro

AU - Esposito, Giovanni

AU - Porcù, Elena

AU - Mitola, Stefania

AU - Lombardi, Giuseppe

AU - Accordi, Benedetta

AU - Tumino, Manuela

AU - Basso, Giuseppe

AU - Persano, Luca

PY - 2016

Y1 - 2016

N2 - Glioblastoma (GBM) is the most devastating tumor of the brain, characterized by an almost inevitable tendency to recur after intensive treatments and a fatal prognosis. Indeed, despite recent technical improvements in GBM surgery, the complete eradication of cancer cell disseminated outside the tumor mass still remains a crucial issue for glioma patients management. In this context, Annexin 2A (ANXA2) is a phospholipid-binding protein expressed in a variety of cell types, whose expression has been recently associated with cell dissemination and metastasis in many cancer types, thus making ANXA2 an attractive putative regulator of cell invasion also in GBM. Here we show that ANXA2 is over-expressed in GBM and positively correlates with tumor aggressiveness and patient survival. In particular, we associate the expression of ANXA2 to a mesenchymal and metastatic phenotype of GBM tumors. Moreover, we functionally characterized the effects exerted by ANXA2 inhibition in primary GBM cultures, demonstrating its ability to sustain cell migration, matrix invasion, cytoskeletal remodeling and proliferation. Finally, we were able to generate an ANXA2-dependent gene signature with a significant prognostic potential in different cohorts of solid tumor patients, including GBM. In conclusion, we demonstrate that ANXA2 acts at multiple levels in determining the disseminating and aggressive behaviour of GBM cells, thus proving its potential as a possible target and strong prognostic factor in the future management of GBM patients.

AB - Glioblastoma (GBM) is the most devastating tumor of the brain, characterized by an almost inevitable tendency to recur after intensive treatments and a fatal prognosis. Indeed, despite recent technical improvements in GBM surgery, the complete eradication of cancer cell disseminated outside the tumor mass still remains a crucial issue for glioma patients management. In this context, Annexin 2A (ANXA2) is a phospholipid-binding protein expressed in a variety of cell types, whose expression has been recently associated with cell dissemination and metastasis in many cancer types, thus making ANXA2 an attractive putative regulator of cell invasion also in GBM. Here we show that ANXA2 is over-expressed in GBM and positively correlates with tumor aggressiveness and patient survival. In particular, we associate the expression of ANXA2 to a mesenchymal and metastatic phenotype of GBM tumors. Moreover, we functionally characterized the effects exerted by ANXA2 inhibition in primary GBM cultures, demonstrating its ability to sustain cell migration, matrix invasion, cytoskeletal remodeling and proliferation. Finally, we were able to generate an ANXA2-dependent gene signature with a significant prognostic potential in different cohorts of solid tumor patients, including GBM. In conclusion, we demonstrate that ANXA2 acts at multiple levels in determining the disseminating and aggressive behaviour of GBM cells, thus proving its potential as a possible target and strong prognostic factor in the future management of GBM patients.

KW - Annexin 2A

KW - Cell cycle

KW - Cytoskeletal remodeling

KW - Glioblastoma

KW - Invasion

UR - http://www.scopus.com/inward/record.url?scp=84983508980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983508980&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.10565

DO - 10.18632/oncotarget.10565

M3 - Article

AN - SCOPUS:84983508980

VL - 7

SP - 54632

EP - 54649

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 34

ER -